FDA Adverse Event Death Summary report: N

ION?

MDR report key: 3052957 · Received April 11, 2013

Report

Report Number
2134265-2013-02315
Event Type
Death
Date Received
April 11, 2013
Date of Event
January 31, 2013
Report Date
March 14, 2013
Manufacturer
BOSTON SCIENTIFIC - MAPLE GROVE
Product Code
NIQ
PMA / PMN Number
P100023
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

DEVICE IS A COMBINATION PRODUCT. DEVICE EVALUATED BY MANUFACTURER - DEVICE NOT RETURNED THEREFORE ANALYSIS OF COMPLAINT DEVICE COULD NOT BE PERFORMED. THE MANUFACTURING BATCH RECORD REVIEW CONFIRMED THAT THE DEVICE MET ALL MATERIAL, ASSEMBLY AND PERFORMANCE SPECIFICATIONS. THE ROOT CAUSE IS ANTICIPATED PROCEDURAL COMPLICATIONS AS THIS EVENT IS A KNOWN PHYSIOLOGICAL EFFECT OF THE PROCEDURE AND IS NOTED WITHIN THE DFU. (B)(4).

Description of Event or Problem · 1

IT WAS FURTHER REPORTED THAT THE PATIENT PRESENTED WITH ACUTE CORONARY SYNDROME, THE TWO ION STENTS WERE PLACED IN THE RIGHT POSTERIOR DESCENDING ARTERY (PDA) AND DISTAL RIGHT CORONARY ARTERY (RCA) RESULTING IN 0% RESIDUAL STENOSIS AND TIMI III FLOW. PATIENT WAS DISCHARGED ON CLOPIDOGREL. IN (B)(6) 2013, THE PATIENT WAS FOUND DOWN, HYPOTENSIVE, AND WITH A FEVER. UPON ARRIVAL TO THE EMERGENCY DEPARTMENT THE PATIENT WAS UNRESPONSIVE, BRADYCARDIC, AND WITHOUT A PULSE. CPR WAS INITIATED, HOWEVER PATIENT DID NOT RESPOND TO RESUSCITATIVE EFFORTS AND EXPIRED.

Description of Event or Problem · 1

(B)(4) STUDY. SAME CASE AS MFR ID # 2134265-2013-02266. IT WAS REPORTED THAT FOLLOWING A STENTING TREATMENT PROCEDURE, PATIENT DEATH OCCURED. THE 3.0X12MM ION AND 2.5X12MM ION STENTS WERE IMPLANTED. IN (B)(6) 2013, 591 DAYS POST INDEX PROCEDURE THE PATIENT EXPIRED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
156124 ION? CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC - MAPLE GROVE H7493902412250 13978435

Patients

Seq Age Sex Outcome Treatment
1 67 YR Death